Whitty: Weight-Loss Drugs Not Enough to Solve UK Obesity Crisis
Professor Chris Whitty warns GLP-1 agonists like Wegovy have significant side effects and calls for stronger action on junk food advertising and food reformulation to address obesity at its source.


